Home / Valsartan / United States
US ATC C09CA03 · updated 2 Nov 2026
Valsartan shortage in United States
Is there a Valsartan shortage in United States?
Yes. As of 2 Nov 2026, 4 Valsartan products are reported short in United States, the first since 19 Nov 2025. No return date has been given. Main reason: not stated.
Also short in Germany, Italy, Ireland, Austria, Norway, Japan. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Valsartan, Tablet, 160 mg (NDC 0378-5814-77) discontinuation | Mylan Pharmaceuticals Inc., a Viatris Company | 19 Nov 2025 | not given | Not stated |
| US | Valsartan, Tablet, 320 mg (NDC 0378-5815-77) discontinuation | Mylan Pharmaceuticals Inc., a Viatris Company | 19 Nov 2025 | not given | Not stated |
| US | Valsartan, Tablet, 40 mg (NDC 0378-5807-93) discontinuation | Mylan Pharmaceuticals Inc., a Viatris Company | 19 Nov 2025 | not given | Not stated |
| US | Valsartan, Tablet, 80 mg (NDC 0378-5813-77) discontinuation | Mylan Pharmaceuticals Inc., a Viatris Company | 19 Nov 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).